Weatherly Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
10,150
-209
-2% -$18.7K 0.07% 102
2026
Q1
$744K Sell
10,359
-29
-0.3% -$2.23K 0.06% 114
2025
Q4
$824K Sell
10,388
-2,008
-16% -$158K 0.06% 111
2025
Q3
$935K Sell
12,396
-732
-6% -$50.2K 0.08% 106
2025
Q2
$906K Buy
13,128
+5
+0% +$328 0.08% 110
2025
Q1
$889K Sell
13,123
-14
-0.1% -$838 0.08% 112
2024
Q4
$590K Sell
13,137
-2,289
-15% -$128K 0.05% 123
2024
Q3
$970K Buy
15,426
+1,699
+12% +$99.1K 0.09% 111
2024
Q2
$811K Sell
13,727
-2,035
-13% -$127K 0.07% 113
2024
Q1
$1.26M Sell
15,762
-1,607
-9% -$123K 0.12% 98
2023
Q4
$1.37M Sell
17,369
-3,284
-16% -$234K 0.15% 90
2023
Q3
$1.44M Sell
20,653
-1,369
-6% -$97K 0.17% 85
2023
Q2
$1.52M Sell
22,022
-924
-4% -$65.7K 0.18% 86
2023
Q1
$1.71M Sell
22,946
-500
-2% -$41.9K 0.22% 80
2022
Q4
$2.18M Sell
23,446
-24
-0.1% -$2.32K 0.3% 66
2022
Q3
$2.24M Buy
23,470
+1
+0% +$99 0.32% 59
2022
Q2
$2.17M Sell
23,469
-212
-0.9% -$20.7K 0.3% 69
2022
Q1
$2.4M Sell
23,681
-140
-0.6% -$14.7K 0.28% 70
2021
Q4
$2.46M Sell
23,821
-1,380
-5% -$128K 0.27% 67
2021
Q3
$2.14M Sell
25,201
-954
-4% -$79.9K 0.26% 73
2021
Q2
$2.18M Sell
26,155
-171
-0.6% -$14K 0.28% 69
2021
Q1
$1.98M Buy
26,326
+194
+0.7% +$14.1K 0.27% 69
2020
Q4
$1.78M Sell
26,132
-874
-3% -$56.8K 0.26% 73
2020
Q3
$1.58M Sell
27,006
-525
-2% -$32.7K 0.25% 72
2020
Q2
$1.79M Hold
27,531
0.32% 56
2020
Q1
$1.63M Sell
27,531
-281
-1% -$18.8K 0.36% 56
2019
Q4
$2.07M Sell
27,812
-650
-2% -$45.6K 0.39% 55
2019
Q3
$1.79M Sell
28,462
-2,133
-7% -$126K 0.38% 58
2019
Q2
$1.67M Sell
30,595
-492
-2% -$26.5K 0.33% 65
2019
Q1
$1.68M Sell
31,087
-219
-0.7% -$13.5K 0.34% 65
2018
Q4
$2.05M Sell
31,306
-1,332
-4% -$99.4K 0.49% 54
2018
Q3
$2.57M Buy
32,638
+157
+0.5% +$11.2K 0.53% 43
2018
Q2
$2.09M Buy
32,481
+12
+0% +$791 0.49% 50
2018
Q1
$2.02M Buy
32,469
+1
+0% +$72 0.48% 49
2017
Q4
$2.35M Buy
32,468
+1,461
+5% +$106K 0.57% 39
2017
Q3
$2.52M Sell
31,007
-567
-2% -$44.9K 0.67% 37
2017
Q2
$2.54M Sell
31,574
-1,499
-5% -$118K 0.72% 37
2017
Q1
$2.6M Sell
33,073
-516
-2% -$41.2K 0.77% 34
2016
Q4
$2.65M Buy
33,589
+3,935
+13% +$318K 0.84% 32
2016
Q3
$2.64M Buy
29,654
+6,550
+28% +$618K 0.88% 31
2016
Q2
$2.21M Sell
23,104
-86
-0.4% -$8.57K 0.73% 37
2016
Q1
$2.4M Buy
23,190
+1,309
+6% +$127K 0.83% 32
2015
Q4
$2.14M Buy
21,881
+678
+3% +$66.4K 0.76% 32
2015
Q3
$2.04M Sell
21,203
-592
-3% -$62.2K 0.83% 28
2015
Q2
$2.29M Sell
21,795
-345
-2% -$35.2K 0.87% 28
2015
Q1
$2.29M Buy
22,140
+1,098
+5% +$111K 0.91% 27
2014
Q4
$2.03M Sell
21,042
-308
-1% -$27.1K 0.85% 34
2014
Q3
$1.7M Buy
21,350
+1,542
+8% +$122K 0.73% 43
2014
Q2
$1.49M Buy
19,808
+85
+0.4% +$6.42K 0.63% 46
2014
Q1
$1.48M Sell
19,723
-287
-1% -$20.3K 0.69% 45
2013
Q4
$1.43M Sell
20,010
-2
-0% -$129 0.68% 45
2013
Q3
$1.14M Sell
20,012
-1,895
-9% -$113K 0.58% 49
2013
Q2
$1.25M Buy
+21,907
New +$1.27M 0.69% 46

Other funds holding CVS

Weatherly Asset Management's CVS Position: Q2 2026 in Review

Weatherly Asset Management reduced its CVS Health (CVS) stake by 2% in Q2 2026, selling an estimated $18.7K and leaving 10,150 shares worth $1.05M. The position accounts for 0.07% of the portfolio, ranked #102.

Weatherly Asset Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.65M in Q4 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Weatherly Asset Management held 10,150 shares of CVS Health worth $1.05M as of Q2 2026.
  • Weatherly Asset Management sold 209 CVS Health shares in Q2 2026, an estimated $18.7K.
  • CVS Health made up 0.07% of Weatherly Asset Management's portfolio in Q2 2026, its #102 holding.
  • Weatherly Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Weatherly Asset Management's CVS Health position peaked at $2.65M in Q4 2016.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Weatherly Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.